Cambridge Team Develops Universal Vaccine To Curb Variants Of Covid, Ebola Infections

In a significant breakthrough, scientists at the University of Cambridge along with DIOSynVax a spin-out company from the same university, have designed Sarbeco coronavirus vaccine using computational simulations that offers broad protection from thousand variants of virus such as Corona or Ebola.